Have a personal or library account? Click to login
Beliefs about medicines’ association with endocrine therapy adherence in early breast cancer survivors in Croatia Cover

Beliefs about medicines’ association with endocrine therapy adherence in early breast cancer survivors in Croatia

Acta Pharmaceutica
Volume 73 (2023): Issue 4 (December 2023)
By: Ana Dugonjić Okroša,  Tajana Silovski,  Natalija Dedić Plavetić,  Hrvoje Silovski,  Ana Kovačić and  Iva Mucalo  
Open Access
|Dec 2023

Authors

Ana Dugonjić Okroša

Agency for Medicinal Products and Medical Devices of Croatia, Zagreb, Croatia

Tajana Silovski

Department of Oncology, University Hospital Centre Zagreb, Zagreb, Croatia
University of Zagreb, Medical School Zagreb, Croatia

Natalija Dedić Plavetić

Department of Oncology, University Hospital Centre Zagreb, Zagreb, Croatia
University of Zagreb, Medical School Zagreb, Croatia

Hrvoje Silovski

University of Zagreb, Medical School Zagreb, Croatia
Department of Surgery, University Hospital Centre Zagreb, Zagreb, Croatia

Ana Kovačić

University of Zagreb Faculty of Food Technology and Biotechnology, Zagreb, Croatia

Iva Mucalo

iva.mucalo@pharma.unizg.hr

University of Zagreb Faculty of Pharmacy and Biochemistry, Zagreb, Croatia
DOI: https://doi.org/10.2478/acph-2023-0043 | Journal eISSN: 1846-9558 | Journal ISSN: 1330-0075
Journal RSS Feed
Language: English
Page range: 673 - 689
Accepted on: Nov 23, 2023
|
Published on: Dec 26, 2023
Published by: Croatian Pharmaceutical Society
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
breast cancer,
adjuvant endocrine therapy,
beliefs about medicines,
medication adherence,
sociodemographic factors,
clinical factors,
hormone-positive breast cancer survivors
Related subjects:
Pharmacy,
Pharmacy, other

© 2023 Ana Dugonjić Okroša, Tajana Silovski, Natalija Dedić Plavetić, Hrvoje Silovski, Ana Kovačić, Iva Mucalo, published by Croatian Pharmaceutical Society
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Previous articleVolume 73 (2023): Issue 4 (December 2023)Next article